Molecular Mechanisms of Natural Killer Cell Cytokine-Activation
自然杀伤细胞细胞因子激活的分子机制
基本信息
- 批准号:7659856
- 负责人:
- 金额:$ 11.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-26 至 2014-03-31
- 项目状态:已结题
- 来源:
- 关键词:Activated Natural Killer CellAddressAdvisory CommitteesAntigensBindingBinding SitesCancer PatientCell-Mediated CytolysisCellsCellular biologyCodeCytokine ActivationCytokine SignalingDatabasesDiseaseDoctor of PhilosophyFosteringFoundationsGene Expression ProfileGenerationsGenesGeneticGenetic TranslationGenomicsGoalsHealthHematologic NeoplasmsHematologyHematopoietic NeoplasmsImmuneImmune systemImmunityIn VitroInternal MedicineLaboratoriesLeadLymphocyteMalignant - descriptorMalignant NeoplasmsMediatingMedicalMedicineMentorsMessenger RNAMicroRNAsMolecularMolecular ProfilingMusNK Cell ActivationNatural Killer CellsPathway interactionsPhysiciansPopulationPost-Transcriptional RegulationPrincipal InvestigatorProtein DatabasesProteinsProteomeProteomicsRegulationResearchRestRoleScientistTechniquesTechnologyTrainingTraining ProgramsTranscriptional RegulationTranslationsUniversitiesVirusWashingtonWorkbasecareercareer developmentcytokinecytotoxiccytotoxicityexperiencegranzyme Bin vivokillingsleukemiamouse modelnoveloncologyparacrinepathogenperforinprogramsprotein expressionprotein profilingresearch study
项目摘要
DESCRIPTION (provided by applicant): The long term goal of this proposal is to train the applicant to become an independent academic physician- scientist studying the innate immune system and its impact on blood cancers. The principal investigator (PI) has completed PhD training focused on the cellular biology of natural killer (NK) cells, and MD training in internal medicine and hematology-oncology. This application describes a 5 year training program that will provide a mentored educational experience aimed at developing new scientific expertise in molecular profiling, massively parallel sequencing, proteomic analysis, manipulation of microRNAs (miRs), and the generation of mouse models. Dr. Timothy Ley will mentor the Pi's scientific and career development. He is a recognized leader in the field of lymphocyte cytotoxicity, in vivo genetic mouse models, and genomic analysis of leukemia. Furthermore, an advisory committee of medical scientist experts will provide additional scientific and and non-scientific career development guidance. The proposed research will evaluate the role of miRs in the regulation of NK cell cytokine activation. Recent work by the PI in Dr. Ley's laboratory identified two critical cytotoxic molecules, granzyme B (GzmB) and perforin (Prf1), that are post-transcriptionally regulated in NK cells. We hypothesize that miRs regulate GzmB and Prf 1 in resting NK cells, and that cytokine-activation releases their block in translation. To address this hypothesis, we propose the following specific aims: 1) We will define the miR expression profiles in resting and cytokine-activated NK cells, and evaluate candidate miRs that may regulate GzmB and Prfl mRNA translation. 2) We will define the mRNA (transcriptome) and protein (proteome) expression profiles of resting and cytokine-activated NK cells, integrate these databases to define the mode of regulation of molecules important during NK cell activation, and define the role of miRs for post-transcriptional regulation. Techniques utilized in the project include miR sequencing, miR microarrays, in vitro and in vivo manipulation of miRs, the generation of a NK cell-specific Cre mouse model, the generation of genetic mouse models deficient in miRs using Cre-Lox, and the global analysis of the NK cell transcriptome and proteome. Washington University provides an ideal setting to train physician-scientists, and will foster an invaluable mentored educational experience for the PI to realize his career goals in academic medicine.
This overall career development proposal will train an independent physician-scientist for a lifetime of research studying the immune system and cancer. As NK cells are key components of immunity to numerous infectious pathogens, and are involved in the immuno-surveillance of malignancy, the research proposed may have far reaching consequences for health and disease. Specifically, a better understanding of NK cell activation may lead to novel immune based strategies to treat hematologic malignancies.
描述(由申请人提供):本提案的长期目标是培养申请人成为研究先天免疫系统及其对血癌影响的独立学术医生-科学家。主要研究者(PI)已完成博士培训,重点是自然杀伤(NK)细胞的细胞生物学,以及内科和血液肿瘤学的MD培训。该申请描述了一个为期5年的培训计划,该计划将提供指导性的教育经验,旨在开发分子分析,大规模平行测序,蛋白质组学分析,microRNA(miR)操作和小鼠模型生成方面的新科学专业知识。蒂莫西·莱伊博士将指导圆周率的科学和职业发展。他是淋巴细胞毒性、体内遗传小鼠模型和白血病基因组分析领域公认的领导者。此外,一个由医学专家组成的咨询委员会将提供更多的科学和非科学职业发展指导。该研究将评估miR在NK细胞细胞因子活化调节中的作用。Ley博士实验室的PI最近的工作确定了两种关键的细胞毒性分子,颗粒酶B(Gzm B)和穿孔素(Prf 1),它们在NK细胞中受到转录后调节。我们假设miR调节静息NK细胞中的GzmB和Prf 1,并且精氨酸激活释放了它们的翻译阻断。为了解决这一假设,我们提出了以下具体目标:1)我们将定义静息和精氨酸激活的NK细胞中的miR表达谱,并评估可能调节GzmB和Prfl mRNA翻译的候选miR。2)我们将定义静息和尼古丁激活的NK细胞的mRNA(转录组)和蛋白质(蛋白质组)表达谱,整合这些数据库以定义NK细胞激活过程中重要分子的调控模式,并定义miR在转录后调控中的作用。该项目中使用的技术包括miR测序,miR微阵列,miR的体外和体内操作,NK细胞特异性Cre小鼠模型的生成,使用Cre-Lox生成miR缺陷的遗传小鼠模型,以及NK细胞转录组和蛋白质组的全球分析。华盛顿大学提供了一个理想的环境,以培养医生科学家,并将促进PI实现他在学术医学的职业目标的宝贵的指导教育经验。
这个整体的职业发展建议将培养一个独立的医生,科学家的研究免疫系统和癌症的一生。由于NK细胞是对许多传染性病原体免疫的关键组成部分,并且参与恶性肿瘤的免疫监视,因此所提出的研究可能对健康和疾病产生深远的影响。具体而言,更好地理解NK细胞活化可能导致新的基于免疫的策略来治疗血液恶性肿瘤。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TODD A FEHNIGER其他文献
TODD A FEHNIGER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TODD A FEHNIGER', 18)}}的其他基金
TRANSLATING NK CELL BIOLOGY INTO CLINICAL CANCER IMMUNOTHERAPY
将 NK 细胞生物学转化为临床癌症免疫治疗
- 批准号:
9767734 - 财政年份:2017
- 资助金额:
$ 11.65万 - 项目类别:
TRANSLATING NK CELL BIOLOGY INTO CLINICAL CANCER IMMUNOTHERAPY
将 NK 细胞生物学转化为临床癌症免疫治疗
- 批准号:
10017898 - 财政年份:2017
- 资助金额:
$ 11.65万 - 项目类别:
Project 5 - Memory-like NK cell augmented hematopoietic cell transplantation for AML.
项目 5 - 记忆样 NK 细胞增强造血细胞移植治疗 AML。
- 批准号:
10439627 - 财政年份:2013
- 资助金额:
$ 11.65万 - 项目类别:
MICRORNA REGULATION OF NK CELL DEVELOPMENT AND FUNCTION
微小RNA对NK细胞发育和功能的调节
- 批准号:
8583090 - 财政年份:2013
- 资助金额:
$ 11.65万 - 项目类别:
MICRORNA REGULATION OF NK CELL DEVELOPMENT AND FUNCTION
微小RNA对NK细胞发育和功能的调节
- 批准号:
8715686 - 财政年份:2013
- 资助金额:
$ 11.65万 - 项目类别:
MICRORNA REGULATION OF NK CELL DEVELOPMENT AND FUNCTION
微小RNA对NK细胞发育和功能的调节
- 批准号:
8890768 - 财政年份:2013
- 资助金额:
$ 11.65万 - 项目类别:
Project 5 - Memory-like NK cell augmented hematopoietic cell transplantation for AML.
项目 5 - 记忆样 NK 细胞增强造血细胞移植治疗 AML。
- 批准号:
10931079 - 财政年份:2013
- 资助金额:
$ 11.65万 - 项目类别:
Project 5 - Memory-like NK cell augmented hematopoietic cell transplantation for AML.
项目 5 - 记忆样 NK 细胞增强造血细胞移植治疗 AML。
- 批准号:
10194404 - 财政年份:2013
- 资助金额:
$ 11.65万 - 项目类别:
MICRORNA REGULATION OF NK CELL DEVELOPMENT AND FUNCTION
微小RNA对NK细胞发育和功能的调节
- 批准号:
9097519 - 财政年份:2013
- 资助金额:
$ 11.65万 - 项目类别:
Molecular Mechanisms of Natural Killer Cell Cytokine-Activation
自然杀伤细胞细胞因子激活的分子机制
- 批准号:
8244451 - 财政年份:2009
- 资助金额:
$ 11.65万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 11.65万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 11.65万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 11.65万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 11.65万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 11.65万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 11.65万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 11.65万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 11.65万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 11.65万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 11.65万 - 项目类别:
Research Grant